The Parkinson–Control Study: A 1-Year Randomized, Double-Blind Trial Comparing Piribedil (150 Mg/Day) with Bromocriptine (25 Mg/Day) in Early Combination with Levodopa in Parkinson's Disease
                        AuthID
P-00G-YYC
                
    P-00G-YYC
 
    
                     
                    